TSHA — Taysha Gene Therapies Inc
In 2026 Q2, 3 of the 140 tracked hedge funds reported a position in Taysha Gene Therapies Inc (TSHA), worth $35.93M combined. Over the quarter 2 opened or added, 2 trimmed or exited.
Hedge fund holders, 2026 Q2
| Fund | Value | Portfolio % | Change |
|---|---|---|---|
| Polar Capital | $34.85M | 0.10% | -9.5% |
| Persistent | $908.53K | 0.29% | NEW |
| Quadrature | $175.38K | 0.00% | +9.6% |
All stocks · Quarterly Trends · Hedge Fund Tracker
Source: SEC EDGAR 13F filings, reported as of quarter end and filed up to 45 days later. Not investment advice.